Across its top 20 institutional holders, NVCR's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 7/100, avg. turnover score 31/100).

Quarterly Activity

Recent Activity

+$617.5M

Total Buy Value

$544.8M

Total Sell Value

New buy30

Trim74

Add78

Sold out50

108

Net Buyers

124

Net Sellers

Smart Money Convergence

NVCR does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

Filings (90d)

$615K

Total Est. Value

34K shares

Planned Shares

Last Filed 2026-06-04

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
Leonard Frank X	Officer	2026-06-04	34K shares	$615K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-06-30

2026-06-30

No AI summary for this filing type

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

G6674U108

FAQ

Who are the top institutional investors holding NovoCure Limited (NVCR)?

Major stakeholders currently include FMR LLC ($186.1M), BlackRock, Inc. ($143.8M), Soleus Capital Management, L.P. ($114.4M). Based on the latest 13F filings, there are a total of 220 tracked investment funds and institutions maintaining positions in NVCR.

What is the overall institutional sentiment toward NVCR recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $164.9M, driven by 108 managers accumulating shares while 124 reduced their exposure.

Which institutions have been selling or reducing their NVCR positions?

In the latest period, 74 funds trimmed their holdings, and 50 managers completely exited their positions. The aggregate reported sell value was $544.8M.

Are there any notable investors adding NVCR to their portfolios?

Yes, buying activity remains notable. 30 institutions opened new positions in {ticker}, and 78 existing holders added to their shares. The total reported buy value for the quarter amounted to $617.5M.